** Shares of Innovent Biologics Inc 1801.HK rise 2.8% to HK$55.25 on their second session of gain, on track for the biggest one-day pct gain since April 24
** The Chinese innovative medicines developer and producer says it achieved total product revenue exceeding 2.4 bln yuan ($330.10 mln) for the first quarter of 2025, maintaining over 40% year-on-year growth
** "The year 2025 is a significant year for the company as it enters a new era of growth and global innovation" - Innovent
** Hang Seng Biotech Index .HSHKBIO gains 0.8%, Hang Seng Index .HSI rises 1.5%
** Stock up 50.7% YTD
($1 = 7.2706 Chinese yuan renminbi)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.